EMILY MCCORMAC: Open Payments
NPI 1730656422 · PONTOTOC, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 11 payments from 5 companies in 2025. Trend: 2023 $343 · 2024 $376 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $103 |
| Supernus Pharmaceuticals, Inc. | 4 | $81 |
| Lundbeck LLC | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: Auvelity, Qelbree, REXULTI, CAPLYTA, FANAPT.
Industry payments across MS — which companies pay providers there.
